Literature DB >> 22695970

Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head?

M S Janot1, S Kersting, O Belyaev, A Matuschek, A M Chromik, D Suelberg, W Uhl, A Tannapfel, U Bergmann.   

Abstract

PURPOSE: According to the International Union Against Cancer (UICC), R1 is defined as the microscopic presence of tumor cells at the surface of the resection margin (RM). In contrast, the Royal College of Pathologists (RCP) suggested to declare R1 already when tumor cells are found within 1 mm of the RM. The aim of this study was to determine the significance of the RM concerning the prognosis of pancreatic ductal adenocarcinoma (PDAC).
METHODS: From 2007 to 2009, 62 patients underwent a curative operation for PDAC of the pancreatic head. The relevance of R status on cumulative overall survival (OS) was assessed on univariate and multivariate analysis for both the classic R classification (UICC) and the suggestion of the RCP.
RESULTS: Following the UICC criteria, a positive RM was detected in 8 %. Along with grading and lymph node ratio, R status revealed a significant impact on OS on univariate and multivariate analysis. Applying the suggestion of the RCP, R1 rate rose to 26 % resulting in no significant impact on OS in univariate analysis.
CONCLUSIONS: Our study has shown that the RCP suggestion for R status has no impact on the prognosis of PDAC. In contrast, our data confirmed the UICC R classification of RM as well as N category, grading, and lymph node ratio as significant prognostic factors.

Entities:  

Mesh:

Year:  2012        PMID: 22695970     DOI: 10.1007/s00423-012-0953-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  32 in total

1.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 2.  Resection margins and R1 rates in pancreatic cancer--are we there yet?

Authors:  C S Verbeke
Journal:  Histopathology       Date:  2007-12-13       Impact factor: 5.087

3.  Surgery for recurrent pancreatic ductal adenocarcinoma.

Authors:  Jörg Kleeff; Carolin Reiser; Ulf Hinz; Jeannine Bachmann; Jürgen Debus; Dirk Jaeger; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

4.  A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

Authors:  Thomas J Howard; Joseph E Krug; Jian Yu; Nick J Zyromski; C Max Schmidt; Lewis E Jacobson; James A Madura; Eric A Wiebke; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

5.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

6.  Redefining the R1 resection in pancreatic cancer.

Authors:  C S Verbeke; D Leitch; K V Menon; M J McMahon; P J Guillou; A Anthoney
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

7.  Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection.

Authors:  Akimasa Nakao; Shin Takeda; Mitsuru Sakai; Tetsuya Kaneko; Soichiro Inoue; Hiroyuki Sugimoto; Naohito Kanazumi
Journal:  Pancreas       Date:  2004-04       Impact factor: 3.327

8.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

9.  Clinical and pathologic prognostic factors for curative resection for pancreatic cancer.

Authors:  M V Perini; A L Montagnini; J Jukemura; S Penteado; E E Abdo; R Patzina; I Cecconello; J E M Cunha
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544

View more
  8 in total

1.  [New S3 guidelines on exocrine pancreatic cancer].

Authors:  A Tannapfel
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

2.  Prognosis of resected pancreatic cancer: is the refined resection margin status dispensable?

Authors:  Werner Hartwig; Jens Werner; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2012-07-21       Impact factor: 3.445

3.  [Update of the S3 guidelines for pancreatic cancer. What is new for pathologists?].

Authors:  J Munding; J Lüttges; I Esposito; A Tannapfel
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 4.  [Pathology of the R1 classification in visceral cancer surgery].

Authors:  M J Pollheimer; C Langner
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

5.  Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?

Authors:  Florian Gebauer; Michael Tachezy; Yogesh K Vashist; Andreas H Marx; Emre Yekebas; Jakob R Izbicki; Maximilian Bockhorn
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

6.  The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Takeo Nitta; Toru Nakamura; Tomoko Mitsuhashi; Toshimichi Asano; Keisuke Okamura; Takahiro Tsuchikawa; Eiji Tamoto; Soichi Murakami; Takehiro Noji; Yo Kurashima; Yuma Ebihara; Yoshitsugu Nakanishi; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Surg Today       Date:  2016-09-27       Impact factor: 2.549

7.  Impact of resection margins on long-term survival after pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Cheng-Gang Li; Zhi-Peng Zhou; Xiang-Long Tan; Yuan-Xing Gao; Zi-Zheng Wang; Qu Liu; Zhi-Ming Zhao
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

Review 8.  Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Authors:  Kyung Su Kim; Jeanny Kwon; Kyubo Kim; Eui Kyu Chie
Journal:  Cancer Res Treat       Date:  2016-08-26       Impact factor: 4.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.